about forethought

forethought access® is a boutique consultancy that focuses on early-stage market access activities for high value healthcare technologies. We believe that the earlier one plans for market access, the better the chances are of maximizing the value of a healthcare technology

Early-stage market access consulting services

UK NICE says draft no to Novartis Kymriah in DBLCL

German G-BA starting Kymriah’s appraisal

NHS England closes deal with Novartis for Kymriah in ALL

German G-BA positive on Takeda’s Darvadstrocel